Uncover H1N1 Early with Tongzhou Biotech's H1N1 Antigen Rapid Test
CK-MB Rapid Test
|
Cat. No. |
C003-4002 |
|
Product Description |
CK-MB Rapid Test |
|
Specimen |
WB/S/P |
|
Format |
Cassette |
|
Kit Size |
10 T |
|
Cut-Off |
5 ng/mL |
|
Status |
CE |
Creatine Kinase MB (CK-MB) is an enzyme present in the cardiac muscle with a molecular weight of 87.0 kDa. Creatine Kinase is a dimeric molecule formed from two subunits designated as “M” and “B” which combine to form three different isoenzymes, CK-MM, CK-BB, and CK-MB. CK-MB is the isoenzyme of Creatine Kinase most involved in the metabolism of cardiac muscle tissue.
The release of CK-MB into the blood following MI can be detected within 3-8 hours after the onset of symptoms. It peaks within 9 to 30 hours, and returns to baseline levels within 48 to 72 hours. CK-MB is one of the most important cardiac markers and is widely recognized as the traditional marker for the diagnosis of MI.
The CK-MB Rapid Test (Whole Blood/Serum/Plasma) is a simple test that utilizes a combination of antibody coated particles and capture reagents to qualitatively detect CK-MB in whole blood, serum or plasma. The minimum detection level is 5 ng/mL CK-MB.
Powered by a unique blend of depth and dynamism, our H1N1 Antigen Rapid Test stands as a beacon of hope amid turbulent health crises. It's a testament to our unwavering commitment to delivering quality diagnostic tools to aid medical practitioners worldwide. With a robust design and exceptional functionality, the H1N1 Antigen Rapid Test guarantees quick, accurate results, enabling early detection and prompt treatment. The H1N1 Antigen Rapid Test Kit from Tongzhou Biotechnology – a manifestation of state-of-the-art bioengineering solutions designed to save lives. Expedite your H1N1 diagnosis with us, embrace rapid results, and stay a step ahead in healthcare management.
